Delta State Partners Sanofi to Tackle Diabetes and Hypertension

Concerned about the rising incidence of diabetes and hypertension among Nigerians, Delta State Government has signed an agreement with multinational Pharmaceutical, Sanofi Aventis to ensure unhindered access to specialised management of the two diseases in the state.

Chairman, Delta State Contributory Health Commission, Dr. Isaac Akpoveta, signed on behalf of the government while General Manager/Country Chair, Nigeria-Ghana, Pharm. Folake Odediran signed on behalf Sanofi at the Commission’s office in Asaba.

Let’s Pay More Attention to Diabetes Among Nigerians-DICOMAG

Dr. Akpoveta, who could not hide his joy, said that the state Governor Ifeanyi Okowa’s administration places high premium on the health of Deltans, thus the establishment of the contributory Health Insurance Scheme.

He described the signing of the MoU as a partnership that would work for the benefit of Deltans and the company, adding that no stone would be left unturned in achieving universal health care delivery system for Deltans.

In her remarks, Odediran said Sanofi’s mission is empowering life, adding that the signing of the MoU, would strengthen healthcare delivery system in the state, especially in the rural areas.

She expressed optimism that the capacity of medical personnel would be up scaled, saying that their aim was to ascertain healthcare needs of the state with a view to offering help or assistance.

(L-R) External Affairs Director Sanofi Nigeria-Ghana, Pharm. Dimeji Agbolade, Director General/ Chief Executive Officer, Delta State Contributory Health Commission, Dr. Ben Nkechika, General Manager/Country Chair, Sanofi Aventis, Folake Odediran, Board Chairman, Dr. Isaac Akpoveta, Head of Medical, Dr. Philip Ikeme and Head, Ethical Business Unit, Sanofi Aventis, Oluwale Akinbowale

She said that the partnership with Delta was due to the fact that the state has a model that is already operational, but however, pointed out that the company has its focus on the entire country.

She described diabetes and hypertension as major public health concern because they impose significant economic burdens on governments, patients and caregivers.

“However, it has also been established that proper disease awareness and good quality of care often lead to very positive outcomes for these conditions. Access to quality care remains a critical need in our environment,” she said.

Odediran further said that the company would be working in collaboration with stakeholders to empower people and healthcare practitioners with the right disease information and capacity to effectively manage the diseases.

 

Also speaking, the Director-General of the Commission, Dr. Ben Nkechika, who gave an overview of the commission, disclosed that a strategy has been adopted by the commission to reach the rural communities, adding that their ultimate goal was to ensure effective and efficient service delivery

 

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: